Search

Your search keyword '"Rodeghiero, F"' showing total 93 results

Search Constraints

Start Over You searched for: Author "Rodeghiero, F" Remove constraint Author: "Rodeghiero, F" Publication Type Electronic Resources Remove constraint Publication Type: Electronic Resources
93 results on '"Rodeghiero, F"'

Search Results

1. Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia

2. Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper

3. Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper

4. Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers

5. Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years

6. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

7. Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report

8. Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report

9. Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper

10. The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting

11. Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

12. Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia

13. Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia

14. Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

15. The european hematology association roadmap for european hematology research: A consensus document

16. EHA Roadmap for European Hematology Research. The European Hematology Association Roadmap for European Hematology Research: a consensus document

17. The European Hematology Association Roadmap for European Hematology Research: a consensus document.

18. The european hematology association roadmap for european hematology research: A consensus document

19. EHA Roadmap for European Hematology Research. The European Hematology Association Roadmap for European Hematology Research: a consensus document

20. The european hematology association roadmap for european hematology research: A consensus document

21. The European Hematology Association Roadmap for European Hematology Research: a consensus document

22. DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma

23. Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia

24. Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia

25. Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia

26. Economic assessment of Eltrombopag in the treatment of thrombocytopenia

27. Economic assessment of Eltrombopag in the treatment of thrombocytopenia

28. Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia

29. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery

30. Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors

31. Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta

32. B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia

33. Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN

34. Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN

35. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)

36. Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation

37. The mining industrial heritage of the Alps and Central Italy: an analysis of recovery and valorisation initiatives in a mineral deposits geology key

38. Idee guida per una valorizzazione del patrimonio minerario del metallifero triassico in Lombardia

39. Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation

40. Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia

41. Phreatic sulphide bearing quartz breccias between Crystalline Basement and Collio formation (Southern Alps, Italy)

42. Guiding lines for the improvement of the triassic Metalliferous mining heritage in Lombardy

44. Systematically missing confounders in individual participant data meta-analysis of observational cohort studies

45. Systematically missing confounders in individual participant data meta-analysis of observational cohort studies

46. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: Incidence, risk factors, and effect of treatments

47. The natural stones used on the Romanesque north wall of the St. Martino church in Mendrisio

48. La presenza di grandi vuoti sotterranei di coltivazioni minerarie dismesse. Problemi conoscitivi ed indagini mirate

49. Miniere e cave non più attive in Lombardia: problema o risorsa?

50. Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)

Catalog

Books, media, physical & digital resources